急性缺血性脑卒中患者血浆PMP及EMP含量与预后的相关性

doi:10.6040/j.issn.1671-7554.0.2016.831

摘要/Abstract

摘要： 目的探讨急性缺血性脑卒中(AIS)患者血浆中血小板微粒体(PMP)和内皮细胞微粒体(EMP)水平与其预后的关系。方法以德州市人民医院神经内科2013年3月至2015年6月收治的56例AIS患者(AIS组)和40例体检者(对照组)为研究对象。对所有研究对象进行问卷调查并抽取5 mL静脉血,采用流式细胞仪检测PMP和EMP含量。对AIS组进行入院和出院NIHSS评分,据此将AIS组分为预后不良和预后良好两类。采用Logistic回归分析探讨影响AIS预后的危险因素。结果 AIS组PMP和EMP水平显著高于对照组(P<0.05)。AIS组中预后良好患者的 PMP和EMP水平显著低于预后不良的患者(P<0.05)。Logistic回归分析发现,糖尿病、高血压、PMP和EMP水平是影响AIS患者预后的独立预测因子。结论血浆PMP和EMP水平可能作为临床上评估AIS预后的指标。

关键词: 急性缺血性脑卒中, 内皮细胞微粒体, 预后, 血小板微粒体

Abstract: Objective To explore the relationship between circulating platelets microparticles(PMP)and endothelial microparticls(EMP)and prognosis in patients with acute ischemic stroke(AIS). Methods Fifty-six patients with AIS(AIS groups)hospitalized from March, 2013 to June, 2015 and 40 people who took health examination in Dezhou Peoples Hospital were selected(Control group), and all subjects were investigated to explore the risk factors of prognosis. Venous blood(5 mL)was extracted from each subject. Flow cytometry was used to detect the levels of PMP and EMP. Patients in AIS group were evaluated by the National Institutes of Health Stroke Scale(NIHSS)in admission and discharge, and were classified into two types, poor prognosis and favorable prognosis, according to the scores. Risk factors that affected prognosis were investigated by the Logistical regression analysis. Results The levels of PMP and EMP in AIS group were significantly higher than those in Control group(P<0.05). The levels of PMP and EMP in patients with favorable prognosis were significantly higher than those with poor prognosis(P<0.05). According to Logistical regression analysis, hypertension,diabetes and levels of circulating PMP and EMP were independent risk factors for the prognosis of AIS patients. Conclusion Circulating PMP and EMP levels are associated with AIS, which play important roles in the prognosis of AIS patients.

Key words: Platelets microparticles, Endothelial microparticles, Acute ischemic stroke, Prognosis

中图分类号:

R743

曲立新,时兴华,杜怡峰. 急性缺血性脑卒中患者血浆PMP及EMP含量与预后的相关性[J]. 山东大学学报（医学版）, 2016, 54(12): 32-36.

QU Lixin, SHI Xinghua, DU Yifeng. Relationship between circulating platelets microparticles and endothelial microparticls and prognosis in patients with acute ischemic stroke[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(12): 32-36.

参考文献

[1] Shin SB, Kim TU, Hyun JK, et al. The prediction of clinical outcome using HbA1c in acute ischemic stroke of the deep branch of middle cerebral artery[J]. Ann Rehabil Med, 2015, 39(6):1011-1017.
[2] Lavallee PC, Labreuche J, Faille D, et al. Circulating markers of endothelial dysfunction and platelet activation in patients with severe symptomatic cerebral small vessel disease[J]. Cerebrovasc Dis, 2013, 36(2):131-138.
[3] Ayers L, Kohler M, Harrison P, et al. Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay[J]. Thromb Res, 2011, 127(4):370-377.
[4] Csongradi E, Nagy B Jr, Fulop T, et al. Increased levels of platelet activation markers are positively associated with carotid wall thickness and other atherosclerotic risk factors in obese patients[J]. Thromb Haemost, 2011, 106(4):683-692.
[5] Schiro A, Wilkinson FL, Weston R, et al. Endothelial microparticles as conveyors of information in atherosclerotic disease[J]. Atherosclerosis, 2014, 234(2): 295-302.
[6] Chen Y, Xiao Y, Lin Z, et al. The role of circulating platelets microparticles and platelet parameters in acute ischemic stroke patients[J]. J Stroke Cerebrovasc Dis, 2015, 24(10):2313-2320.
[7] 孔德燕. 腔隙性脑梗死患者脑微出血与循环内皮微粒的相关性研究[J]. 中华老年心脑血管病杂志, 2015, 17(6): 610-612. KONG Deyan. Correlation between cerebral microbleeds and circulating endothelial microparticles in lacunar stroke patients[J].Chin J Geriatr Heart Brain Vessel Dis, 2015, 17(6): 610-612.
[8] 中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中国全科医学,2011,35(14):4013-4017.
[9] Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment[J]. Stroke, 1993, 24(1):35-41.
[10] Burnouf T, Goubran HA, Chou ML, et al. Platelet microparticles: detection and assessment of their paradoxical functional roles in disease and regenerative medicine[J]. Blood Rev, 2014, 28(4):155-166.
[11] Chen J, Chen S, Chen Y, et al. Circulating endothelial progenitor cells and cellular membrane microparticles in db/db diabetic mouse: possible implications in cerebral ischemic damage[J]. Am J Physiol Endocrinol Metab, 2011, 301(1): E62-71.
[12] Miedema I, Uyttenboogaart M, Koch M, et al. Lack of association between serum uric acid levels and outcome in acute ischemic stroke[J]. J Neurol Sci, 2012, 319(1-2): 51-55.
[13] Ferraris VA. Microparticles: the good, the bad, and the ugly[J]. J Thorac Cardiovasc Surg, 2015,149(1): 312-313.
[14] Nadaud S, Poirier O, Girerd B, et al. Small plateletmicroparticle levels are increased in pulmonary arterial hypertension[J]. Eur J Clin Invest, 2013, 43(1): 64-71.
[15] Kumral E, Saruhan G, Aktert D, et al. Association of hyperhomocysteinemia with stroke recurrence after initial stroke[J]. J Stroke Cerebrovasc Dis, 2016, 25(8):2047-2054.
[16] Gremmel T, Ay C, Riedl J, et al. Platelet-specific markers are associated with monocyte-platelet aggregate formation and thrombin generation potential in advanced atherosclerosis[J]. Thromb Haemost, 2016, 115(3):615-621.
[17] Cherian P, Hankey GJ, Eikelboom JW, et al. Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes[J]. Stroke, 2003, 34(9): 2132-2137.
[18] Ribo M, Flores A, Mansilla E, et al. Age-adjusted infarct volume threshold for good outcome after endovascular treatment[J]. J Neurointerv Surg, 2014, 6(6): 418-422.
[19] Tikhonoff V, Zhang H, Richart T, et al. Blood pressure as a prognostic factor after acute stroke[J]. Lancet Neurol, 2009, 8(10): 938-948.
[20] Yong M, Kaste M. Dynamic of hyperglycemia as a predictor of stroke outcome in the ECASS-II trial[J]. Stroke, 2008, 39(10): 2749-2755.

相关文章 15

[1]	栗英林,宋道庆,徐忠华. 应用生物信息学方法分析肾透明细胞癌中FKBP11的表达[J]. 山东大学学报 (医学版), 2020, 1(9): 45-51.
[2]	史爽,李娟,米琦,王允山,杜鲁涛,王传新. 胃癌miRNAs预后风险评分模型的构建与应用[J]. 山东大学学报 (医学版), 2020, 1(7): 47-52.
[3]	路璐,孙志钢,张楠. 继发性嗜血细胞综合征1例[J]. 山东大学学报 (医学版), 2020, 1(7): 122-124.
[4]	李星凯,刘战业,姜运峰,李军. 原发性中央型和周围型肺鳞癌临床病理学及预后差异[J]. 山东大学学报（医学版）, 2017, 55(9): 73-78.
[5]	宗帅,肖东杰,刘华,郏雁飞,马晓丽,李焕杰,黎娉,郑燕,汪运山. CSN5在胃癌中的表达及与患者预后的相关性[J]. 山东大学学报（医学版）, 2017, 55(7): 12-16.
[6]	孙启晶,陈方方,李春晓,张才擎. PNI及HGB评估中晚期非小细胞肺癌患者预后的临床价值[J]. 山东大学学报（医学版）, 2017, 55(4): 55-59.
[7]	董尧,宋亚林,田涛,高建国. 确诊8年未经治疗却无明显进展的阴茎恶性黑色素瘤1例报道[J]. 山东大学学报（医学版）, 2017, 55(3): 125-126.
[8]	林家香,郭子嘉,苏鹏,王晓,郭雅欣,吴晓娟,相磊,周志强, 王妍,崔秀杰,潘爱凤,郭成浩. 致癌蛋白CIP2A在乳腺导管上皮恶变中的作用及预测浸润性导管癌患者预后的能力[J]. 山东大学学报（医学版）, 2017, 55(3): 100-106.
[9]	周兰兰,潘学谊,郭煜. 48例急性混合细胞表型白血病患者的临床特征及预后[J]. 山东大学学报（医学版）, 2017, 55(2): 79-83.
[10]	张希英,翟春颜,李劲松,韩博. 中国尤文肉瘤患者EZH2蛋白表达与临床病理学参数及预后的关系[J]. 山东大学学报（医学版）, 2017, 55(2): 84-91.
[11]	刘惠苓,王兴文,冯少滨,冯虹,韩俊庆. B类I型清道夫受体的高表达与结肠癌患者预后的相关性[J]. 山东大学学报（医学版）, 2017, 55(10): 84-89.
[12]	李晓宁,崔连群. 急性心肌梗死合并多支血管病变患者非梗死相关动脉处理的时机[J]. 山东大学学报（医学版）, 2016, 54(8): 50-54.
[13]	王雯,刘尧,龙飞,马卫霞,苏莉莉. 外周血淋巴细胞/单核细胞比值与恶性胸膜间皮瘤患者预后的关系[J]. 山东大学学报（医学版）, 2016, 54(8): 72-77.
[14]	刘童,张欣,王传新. IRX5 mRNA在结直肠癌诊断及预后中的价值[J]. 山东大学学报（医学版）, 2016, 54(7): 69-74.
[15]	马琳,张冬,唐蕾,叶嗣源,焉传祝,曹丽丽. 肌萎缩侧索硬化预后相关的血液学标志物[J]. 山东大学学报（医学版）, 2016, 54(4): 46-50.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed